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Background: Malaria is a devastating parasitic disease trans-
mitted through the bite of infected female anopheles mosquito.
Complicated life threatening malaria is usually caused by plas-
modium falciparum, but the incidence of complicated malaria
caused by plasmodium vivax is on the rise.
A general shift in the clinical proﬁle of plasmodium vivax with
multiorgan dysfunction is becoming common.
The antimalarial drug policy suggests that all plasmodiumvivax
cases should be treated with chloroquine in full therapeutic doses.
ACT (Artesunate+Sulphadoxine/Pyrimethamine) is advised for
chloroquine resistant and complicated cases.
Objective :
To study incidence of vivax malaria, clinical proﬁle and course
of the disease.
Methods & Materials: All cases of conﬁrmed malaria, clinically
diagnosed asmalaria and treatedwith antimalarialswere analysed.
This study was done at PESIMSR, kuppam.
Results: A total of 170 cases of malaria were analysed of which
35 were complicated malaria. Among them 10 were vivax positive
while 10 were clinically started on antimalarials, while remaining
15 were falciparum positive.
Of the remaining 135 cases, 95 were clinical malaria diagnosed
on the basis of presentation of fever with chills and splenomegaly,
and other causes of fever were ruled out by relevant investigations.
These patients were started on chloroquine or/and ACT depending
on the severity. Of the remaining 40 cases, 16 were positive for
vivax, 8 for both vivax and falciparum.
Thus 46 were positive for vivax (20%) compared to falciparum
(22.94%) among the conﬁrmed cases, thus conﬁrming an increasing
incidence of vivax malaria in recent times.
Mortality was 2 (1.17%)of the total vivax cases.
Conclusion: Malaria was positive in 38.23% of the total
cases treated for malaria and the remaining were clini-
cally/therapeutically proven malaria cases. This shows that vivax
malaria is increasing in areas of endemicity and same importance
has to be given in managing the cases similar to falciparum.
Clinically proven malaria patients had palpable spleen as a clin-
ical sign in suspected cases of malaria along with fever with chills.
High index of suspicion and early initiation of treatment helps in
good recovery of patients.
http://dx.doi.org/10.1016/j.ijid.2016.02.791
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Background: There is dire lack of data regarding the epi-
demiology of human scabies (HS) in sub-Saharan African prisons,
especially in Cameroon, a Central African country. The purpose of
this study was to assess the prevalence and drivers of HS in prisons
of the West Region of Cameroon.
Methods & Materials: From June to August 2014, 755 vol-
unteer inmates were consecutively recruited in three randomly
selected prisons of the region. Each participant underwent a clini-
cal assessment independently conducted by two experienced and
well-trained dermatologists. The diagnosis was ascertained if the
patient complained of pruritus, especially prevailing at night, with
pruritus in the entourage and/or contamination, associated with
the presence of speciﬁc or non-speciﬁc lesions of HS, peculiarly
found at meaningful body sites. Logistic regression analyses served
to identify the drivers of HS.
Results: Ages of participants ranged from 14 to 82 years with
a mean of 32 ± 12 years. There were 17 (2.3%) women. Overall,
242 cases of HS (32.1%; 95% conﬁdence interval (CI): 28.8-35.4%)
were recorded. Duration of incarceration was signiﬁcantly lower
among prisoners with scabies than in those without (p =0.006).
The number of detainees sharing their clothes/bedding (197/242
vs 278/513) and the number of detainees per cell (median 25 vs
17) were signiﬁcantly higher in infected prisoners when compared
to those non-infected p< 0.0001). In multivariable logistic regres-
sion analysis, low educational level (adjusted odds ratio (aOR) 1.9,
95% CI: 1.4 – 2.7; p<0.0001), sharing of clothes/bedding (aOR 2.7,
95% CI: 1.8 – 4.1; p<0.0001), and number of detainees per cell >10
(aOR 1.9, 95% CI: 1.3 – 2.8; p =0.002) were the three independent
factors signiﬁcantly impacting the occurrence of scabies. Age, sex,
duration of incarceration, number of baths per week and number
of washing per week were not associated with HS.
Conclusion: Human scabies is very common in prisons of the
West Region of Cameroon. Loweducational level, sharing of clothes
or bedding and number of detainees/cell > 10 are independent
determinants increasing the likelihood to develop scabies in these
milieus.
http://dx.doi.org/10.1016/j.ijid.2016.02.792
